Non-Invasive Method of Harnessing Muscle’s Secretions for Combating Cancer
Professor Alfredo Franco-Obregón's team found that brief magnetic pulses prompt muscle cells to release secretions that curb breast cancer cell growth and invasion, an effect that depends on the protein HTRA1.
Read the original paper
The potential for muscles to combat cancer has taken a significant leap forward with the discovery of a new method that uses low amplitude and low frequency pulsing magnetic fields (PEMFs) to safely stimulate muscle cells. This novel approach aims to harness the natural secretions of muscle cells, which have been found to contain powerful anticancer properties. By leveraging these secretions, researchers hope to develop a non-invasive strategy to reduce cancer cell growth and invasiveness, particularly in breast cancer.
This groundbreaking research, led by Professor Alfredo Franco-Obregón and Dr. Yee Kit Tai from the National University of Singapore was published in the open access journal Cells. The research team demonstrated that a single 10 minute exposure to low energy PEMFs could induce muscle cells to release a secretome with potent anticancer properties. The study further highlights the critical role of High-Temperature Requirement A1 (HTRA1), a protein that was shown to be necessary and sufficient for the observed anticancer effects. “The secretome’s ability to suppress tumor growth and vascularity was markedly enhanced by the magnetic stimulation of the muscle cells donating the secretome,” noted Professor Franco-Obregón.
In the experiments, conditioned media from the PEMF-exposed muscle cells reduced the proliferation and invasion of several breast cancer cell lines, including the MCF-7 and more malignant MDA-MB-231 human breast cancer cell lines. When administered to breast cancer microtumors implanted onto the chorioallantoic membrane of chicken eggs, the PEMF-conditioned media significantly decreased the size of the microtumors as well as reduced the formation of new blood vessels that would otherwise support the growth of the tumours. Dr. Tai explained, “Our results indicate that the secretome produced by magnetically stimulated muscle cells can effectively target and diminish cancer cell growth and spread.”
A striking aspect of this study is the adaptability and increased potency of the secretome following repeated PEMF exposure. By preconditioning muscle cells in tissue culture with PEMF-generated pCM, the researchers were able to stimulate the production of muscle cells’ anticancer secretome response both in vitro and in vivo. “This preconditioning paradigm showcases a novel in vitro methodology to recreate the manner in which exercise adapts skeletal muscles to constitutively produce anticancer factors, but now, in isolated cultured muscle cells for the clean purification of generated anti-cancer factors for therapeutic exploitation. Furthermore, when our magnetic therapeutic platform is employed in the context of a person with cancer it may amplify the body’s natural anticancer defenses, similarly to exercise, but without the need for strenuous exercise, which may not be feasible for many cancer patients,” Professor Franco-Obregón added.
The BICEPS laboratory research team also explored the underlying mechanisms responsible for the observed anticancer effects. They identified HTRA1 as a key player in mediating these effects, as its upregulation in the pCM was essential for reducing cancer cell viability. The study further demonstrated that recombinant HTRA1 could mimic the anticancer properties of the pCM, while the depletion of HTRA1 from the PEMF-conditioned media abolished these effects. “HTRA1’s role in this process is crucial and highlights its potential as a therapeutic target,” remarked Dr. Tai.
These provocative in vitro and ex vivo results were validated in mice that either had been exercised (twice weekly) or given magnetic stimulation (once per week for 10 minutes) for 8 weeks. Blood from either group of mice were shown to inhibit breast cancer cell growth and invasion as well as showed elevated levels of HTRA1 relative to control mice that had not been exercised nor given magnetic therapy.
The implications of this research are indeed profound, offering a promising non-invasive strategy for leveraging the muscle secretome for cancer therapy. The findings could pave the way for new clinical applications, particularly for patients unable to participate in regular physical exercise. Professor Franco-Obregón concluded, “Our study opens up new avenues for cancer treatment by safely releasing and utilizing the natural bioactive agents released by muscle cells, providing a novel approach to cancer prevention and management.”
About the researchers
Journal reference
Tai, Y.K., Iversen, J.N., Chan, K.K.W., Fong, C.H.H., Abdul Razar, R.B., Ramanan, S., Yap, L.Y.J., Yin, J.N., Toh, S.J., Wong, C.J.K., Koh PEA, Huang RYJ, Franco-Obregón A (2024). Secretome from Magnetically Stimulated Muscle Exhibits Anticancer Potency: Novel Preconditioning Methodology Highlighting HTRA1 Action. Cells, 13, 460. DOI: https://doi.org/10.3390/cells13050460
Wong CJK, Tai YK, Jasmine Lye Yee Yap, Fong CHH, Loo LSW, Kukumberg M, Fröhlich J, Zhang S, Jing Ze Li, Wang JW, Rufaihah AJ, Franco-Obregón A (2022). Brief exposure to directionally-specific pulsed electromagnetic fields stimulates extracellular vesicle release and is antagonized by streptomycin: a potential regenerative medicine and food industry paradigm. Biomaterials, 287, 121658.DOI: https://doi.org/10.1016/j.biomaterials.2022.121658




